GlaxoSmithKline secured approval from the FDA to supply its influenza vaccine, Fluarix Quadrivalent, to CDC distribution centers and health care providers in the U.S. Fluarix was approved by the FDA last year to protect adults and children 3 and older against four strains of flu. The CDC ordered more than 4 million doses of the vaccine.
FDA OKs Glaxo to supply 4-strain flu vaccine in the U.S.
SmartBrief Job Listings for Health Care
|Assistant General Counsel, Regulatory||
|MGR POST MARKET STUDIES - 14000001LK||
|Santa Ana, CA|
|Senior Financial Analyst - Growing Manager Care Health Org||
Fallon Community Health Plan
|Sr Manager, Business Conduct||
|Foster City, CA|
|Chief Executive Officer||